Home / Resources / A Guide to Patient Engagement and Recruitment Solutions
REPORT

A Guide to Patient Engagement & Recruitment Solutions

Clinical trials have grown in complexity over the past decades, making it exceedingly difficult to recruit participants. This guide focuses on common challenges faced in patient recruitment, providing tips on how to best address them through the use of a patient engagement and recruitment solution.

''
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.
Related products
Clinical trial participant discussing trial details
Citeline Connect
世界中の臨床試験の参加者を見つけて教育し、参加させ、登録するためのエンドツーエンドのソリューション
Blocks showing the network behind the Patient Recruitment Collective, speeding up the process of patients to their trials.
Citeline Connect Marketplace
100社以上のリクルートメント組織による強力なネットワークが、より効率的かつ効果的な治験参加者の登録を支援
Citeline Connect HCP awareness connecting to physicians
HCP Awareness
リアルワールドデータとグローバルな医療提供者のネットワークが組み合わさり、臨床試験の認知度を向上させる

Related resources

10 Ways to Set Up Your Sites for Recruitment Success
JUL 15, 2024
Article
Clinical

10 Ways to Set Up Your Sites for Recruitment Success

Taking these steps can better support your sites to be more effective in recruiting the necessary patients needed to make your trial a success.

''
MAY 07, 2024
Infographic
Patient Engagement & Recruitment

Uncover the Right Patients & Boost Trial Enrollment

Citeline PatientMatch leverages a comprehensive view of patients, diseases, and providers to precisely identify protocol-specific populations within your site network.

Recruitment. Retention. ROI. Enlisting a multipronged approach for enrollment success
AUG 13, 2024
Use Case
Clinical

Recruitment. Retention. ROI. Enlisting a multipronged approach for enrollment success

This use case illustrates how Citeline Connect can help engage, recruit, enroll, and track patients for a Phase IV clinical trial.

View all